PCV-VG in Pediatric Laparoscopic Surgery
Launched by ASSIUT UNIVERSITY · Jan 29, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different methods of breathing support for children undergoing laparoscopic surgery, which is a type of minimally invasive surgery. The researchers want to see how a specific breathing technique called Pressure Controlled Ventilation - Volume Guarantee (PCV-VG) compares to two other methods: Volume Control Ventilation (VCV) and Pressure Control Ventilation (PCV). The goal is to understand how these techniques affect children's breathing and oxygen levels during surgery.
To participate in this study, children aged 1 to 8 years old who are scheduled for elective abdominal or urologic laparoscopic surgery may be eligible, provided they have a good overall health status (ASA physical status I-II) and a body mass index (BMI) within a certain range. However, children with serious health issues, lung diseases, or other specific conditions will not be included. Participants can expect to have their breathing monitored closely during the surgery, and their information will help doctors learn more about the best ways to support young patients' breathing during procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA physical status I-II.
- • Both sexes.
- • Age: 1-8 years old.
- • Scheduled for elective abdominal or urologic laparoscopic surgery.
- • BMI between the 5th and 95th percentiles.
- Exclusion Criteria:
- • ASA physical status more than II.
- • Pre-existing lung disease.
- • Pre-operative chest infection.
- • Any thoracic deformities.
- • Unsatisfactory pre-operative arterial oxygen saturation or haemoglobin level.
- • Patients with cardiac, hepatic, or renal diseases.
- • BMI above and below the 95th and 5th percentile respectively.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, Asyut, Egypt
Patients applied
Trial Officials
Hala S Abdel-Ghaffar, MD
Study Director
Assiut University
Yara H Abbas, MD
Study Director
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported